Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: Alligator Bioscience Appoints Johan Giléus as CEO – Søren Bregenholt ...

(PR-inside.com) Alligator Bioscience (STO:ATORX)

Johan Giléus, currently CFO, has been appointed CEO effective 1 January 2027 Søren Bregenholt will remain CEO until 31 December 2026, ensuring a seamless transition Johan Giléus will combine the CEO and CFO roles, reflecting the refocusing of Alligator towards its financial interest in HLX22 LUND, SE / ACCESS Newswire / October 4, 2026 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a biotechnology company whose principal value driver is a financial interest in the HER2-targeting antibody programme HLX22, today announced that the Board of Directors has appointed Johan Giléus as Alligator's new Chief Executive Officer (CEO), effective 1 January 2027. ..

https://reports.pr-inside.com/alligator ... 230029.htm
Copyright PR-Inside.com 2026